Panacea Biotec Share Price

₹ 335.95

-₹16.90 (-4.79%)
1D
Last updated 20 Nov, 2026, 15:52 IST
NSE: PANACEABIO
|
Pharmaceuticals

Panacea Biotec Share Price Today

As of 21 Nov 2026, Panacea Biotec share price is ₹335.95. The stock opened at ₹351.80, compared to its previous close of ₹352.85. During today's trading session, Panacea Biotec share price moved in the range of ₹331.35 to ₹353.40, with an average price of ₹342.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹292.40 and a high of ₹647.00.

Share price over the last 1 day fell from 350.00 to 337.00, ranging between 334.85 and 352.75.

₹331.35
4.79% down today
₹353.40
1D LOW
1D HIGH

Panacea Biotec Stock Insights

Latest Earning
Op Profit TrendUp by 375.91% QoQ
Latest Earning
Net Profit TrendUp by 441.36% QoQ
Latest Earning
Revenue TrendUp by 13.27% YoY
Stock Performance
OutperformingBeat Nifty by 4.35 % in last 1 year
Shareholding Pattern
DIIDII increased stake by 9.52%
Shareholding Pattern
FIIFII increased stake by 19.06%
Panacea Biotec stock performance
Open₹351.80
High₹353.40
Low₹331.35
Prev. close₹352.85
Panacea Biotec trading activity
Volume1,33,412
Average traded price₹338.98
Last traded time03:52:47 20 Nov
Last traded quantity1

Circuit
L
H
₹268.80
₹403.10
52-week
L
H
₹292.40
₹647.00
Mkt Cap Cr
2,059.56

P/E
120.95

P/B
2.42

ROA
1.28%
ROE
1.27%

ROCE
2.24%

Quick Ratio
0.92

EV/EBITDA
33.96

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Panacea Biotec has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Panacea Biotec appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Panacea Biotec revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,56,593.4441.565.119.61%13.79%18.65%2.3123.5
Divis Laboratories2,96,740.7888.2416.4915.31%18.69%23.83%3.558.55
Torrent Pharmaceuticals1,75,577.8085.159.734.7%11.42%11.37%0.7533.59
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.54
Zydus Lifesciences1,19,700.4627.824.37.63%15.1%14.86%0.9116.05
Dr. Reddy's Laboratories1,16,770.9642.313.014.79%7.21%8.58%1.3519.69
Cipla1,14,396.9540.093.236.6%8.18%10.8%2.521.62
Mankind Pharma1,08,630.8647.996.187.82%12.76%14.68%0.7426.29
Aurobindo Pharma1,03,297.5926.082.646.46%10.13%12.76%1.1512.46
Lupin91,412.8717.63.8213.08%21.65%24.54%1.4210.24

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Panacea Biotec Company Background

ISIN
INE922B01023
Sector Market Cap
₹ 2,059.56 Cr

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.

Panacea Biotec Financial Highlights

  • Revenue: Panacea Biotec reported revenue of ₹656.67 crore in FY26 vs ₹579.75 crore in FY25. It showed an increase of 13.27% on a yearly basis.
  • Operating Profit: Panacea Biotec reported an operating loss of ₹7.37 crore in FY26 vs ₹7.95 crore in FY25. It showed an increase of 7.30% on a year-on-year basis.
  • Net Profit: Panacea Biotec reported a net loss of ₹7.16 crore in FY26 vs ₹8.72 crore in FY25. It showed an increase of 17.89% on a yearly basis.

Panacea Biotec Quarterly Result Highlights

  • Panacea Biotec reported revenue of ₹196.27 crore in Sep 2026, compared with ₹203.81 crore in Jun 2026, representing a decrease of 3.70% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported an operating profit of ₹16.99 crore in Sep 2026, compared with ₹3.57 crore in Jun 2026, representing an increase of 375.91% on a quarter-on-quarter (QoQ) basis.
  • Panacea Biotec reported a profit of ₹11.91 crore in Sep 2026, compared with ₹2.20 crore in Jun 2026, reflecting an increase of 441.36% on a QoQ basis.
  • The earnings per share (EPS) of Panacea Biotec stood at ₹0.88 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.48%
FII
2.75%
Other DII
2.47%
Retail and other
22.30%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.36%
Mar 20261.60%
Jun 20262.31%
Sep 20262.75%

Panacea Biotec Investment Returns

1 day
--

1 week
--

1 month
--

1 year
--

3 years
--

5 years
--

Panacea Biotec Share Price History

Panacea Biotec share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹351.80 / ₹335.95
-4.79%
19 Nov 26
₹353.05 / ₹352.85
-1.04%
18 Nov 26
₹360.20 / ₹356.55
+1.09%
17 Nov 26
₹352.60 / ₹352.70
+0.31%
Show more

Panacea Biotec Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹639.77₹559.09₹559.17₹459.95
Other Income₹16.90₹20.66₹25.80₹51.66
Total Revenue₹656.67₹579.75₹584.96₹511.61
Total Expenses₹683.54₹623.70₹619.52₹601.47
Profit Before Tax-₹7.37-₹7.95₹1.48₹12.81
Tax-₹0.21₹0.77₹2.98₹46.55
Profit After Tax-₹7.16-₹8.72-₹1.51-₹33.75
EPS - Basic-₹0.88-₹1.37-₹0.19-₹5.43
EPS - Diluted-₹0.88-₹1.37-₹0.19-₹5.43

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹7.37-₹7.95₹1.48₹12.81
Income before WC changes₹9.16-₹17.82-₹7.28-₹83.06
Change in Assets₹32.89-₹101.58-₹0.85-₹13.27
Change in Liabilities-₹18.92₹93.00₹10.54-₹323.65
Change in WC₹13.98-₹8.58₹9.69-₹336.91
Cash flow from Operations₹16.69-₹27.37-₹0.10-₹422.45
Cash flow from Investing-₹40.50₹64.98₹10.23₹430.33
Cash flow from Financing-₹1.06-₹2.66-₹2.81-₹18.37
Total Cash Flow-₹24.86₹34.95₹7.32-₹10.49
Cash (Start of the year)₹82.13₹47.17₹39.85₹50.35
Cash (End of the year)₹57.31₹82.13₹47.17₹39.85

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹749.13₹713.27₹755.49₹708.85
Current Assets₹513.05₹576.47₹485.18₹562.32
Total Assets₹1,262.18₹1,289.75₹1,240.67₹1,271.17
Current Liabilities₹348.69₹366.99₹308.83₹329.73
Net Current Asset₹164.36₹209.48₹176.35₹232.59
Non-Current Liabilities₹84.61₹92.14₹93.61₹101.32
Equity Capital₹828.88₹830.62₹838.23₹840.11
Total Equity & Liabilities₹1,262.18₹1,289.75₹1,240.67₹1,271.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹413.49₹309.86₹359.60₹257.07
Other Income₹18.00₹16.62₹24.91₹34.44
Total Revenue₹431.50₹326.47₹384.51₹291.50
Total Expenses₹475.37₹352.53₹380.31₹354.25
Profit Before Tax-₹43.88-₹26.06₹4.21-₹62.75
Tax-₹13.97-₹10.83₹0.66₹24.79
Profit After Tax-₹29.91-₹15.23₹3.55-₹87.54
EPS - Basic-₹4.88-₹2.49₹0.58-₹14.29
EPS - Diluted-₹4.88-₹2.49₹0.58-₹14.29

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹43.88-₹26.06₹4.21-₹62.75
Income before WC changes-₹1.88₹3.87₹30.95-₹52.32
Change in Assets-₹6.73-₹50.40₹0.78₹5.19
Change in Liabilities-₹27.26₹51.58₹3.22₹37.48
Change in WC-₹33.99₹1.18₹4.00₹42.67
Cash flow from Operations-₹40.17₹3.94₹33.07-₹10.74
Cash flow from Investing-₹18.53-₹60.60-₹46.80₹2.41
Cash flow from Financing₹22.54₹90.07₹12.82₹9.01
Total Cash Flow-₹36.16₹33.41-₹0.91₹0.67
Cash (Start of the year)₹38.50₹5.09₹6.01₹5.33
Cash (End of the year)₹2.42₹38.50₹5.09₹6.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹567.91₹544.44₹570.30₹524.77
Current Assets₹284.49₹325.02₹183.49₹199.13
Total Assets₹852.40₹869.47₹753.79₹723.90
Current Liabilities₹285.21₹351.40₹249.14₹250.85
Net Current Asset-₹0.72-₹26.38-₹65.65-₹51.72
Non-Current Liabilities₹281.98₹204.10₹175.51₹147.40
Equity Capital₹285.21₹313.97₹329.14₹325.65
Total Equity & Liabilities₹852.40₹869.47₹753.79₹723.90
* All values are in INR Crore
Panacea Biotec market depth
Bid quantityBid priceAsk priceAsk quantity
186335.9500
0000
0000
0000
0000
Total bid quantity186
Total ask quantity0
Panacea Biotec technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
43.51
Neutral

ATR (14)
16.52
Neutral

STOCH(9,6)
8.91
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
29.48
Bearish

UO(9)
38.86
Neutral

ROC(12)
-2.57
Bearish

WillR(14)
-82.76
Bullish
Period
Simple value
Exponential vaue

5D
349.93
347.94

10D
353.58
349.02

20D
341.81
347.88

50D
354.3
359.49

100D
401.46
379.38
Volume trend — traded volume by day
20 Nov1L
19 Nov0L
18 Nov1L
17 Nov0L
16 Nov5L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Panacea Biotec
Pharmaceuticals
Add Stock
Add Another

Panacea Biotec Returns Calculator

Panacea Biotec Latest News

5 months ago
Panacea Biotec shares soar 15% to 52-week high on launch of EU-funded DENSTAR project; what investors need to know
Showing news item 1 of 1

Panacea Biotec Share Price FAQs











Please be aware that Panacea Biotec stock prices are subject to continuous fluctuations due to various factors.